🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on October 14 at 51 years old after a private battle with pancreatic malignancy.

“The shining star of our family has dimmed his light for us in the present world,” his family stated. “After a prolonged and brave struggle with the disease, we are heartbroken to announce that D’Angelo, known to his fans around the world as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on music with his pioneering modern soul style and partnerships with renowned musicians.

He launched his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The record achieved No. 4 on Billboard’s Top R&B Albums chart, went platinum soon after, and earned multiple Grammy nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that propelled his artistic journey into the limelight. The record premiered at the top spot on each of the R&B charts and the Billboard 200. He won two Grammys: Best R&B Album and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a icon, albeit a hesitant one, in the cultural zeitgeist. The personal depiction showed the artist, famously bare to his waist, singing straight into the lens.

D’Angelo stepped back from the public eye after putting out Voodoo and openly battled with drugs and alcohol. In 2005, he was involved in a serious car crash that put him in grave health.

More than a decade later, his third and final album, “Black Messiah” (2014), reaffirmed his lasting popularity with a further top chart entry on the soul music rankings and a award for Best R&B Album.

Once more, in his own enigmatic way, D’Angelo had limited public appearances in the following years.

The singer was announced as a top act for the 2025 music event, but his performance was called off, citing an “unexpected health issue.”

Although details are sparse about D’Angelo’s health in the months before his death, he had apparently been in the hospital for an extended period and in hospice for a fortnight.

D’Angelo’s passing is a stark reminder of the devastating effects of pancreatic malignancy, one of the most deadly and hardest to prevent types of the disease, on a brilliant talent whose life was ended too soon.

“We are saddened that he can only leave dear memories with his loved ones, but we are eternally grateful for the legacy of deeply emotional music he leaves behind,” his kin expressed.

Pancreatic Cancer: Deadly and Difficult to Avoid

Pancreatic malignancy affects the digestive organ, a small organ that generates the hormone insulin and plays an essential role in digestion, among other functions. The position and dimensions of the organ in the body make it more difficult to identify malignancy.

Although pancreatic cancer makes up only approximately three percent of malignancy cases annually in the U.S., it is causes 7% of cancer deaths.

Nearly 70,000 individuals will be diagnosed with this condition and about 52,000 will die of the disease in 2025.

“This malignancy is one of the most lethal diseases, with an aggressive tumor and poor prognosis. We have few and poor treatment options, and a smaller window to make a meaningful impact on the lives of patients,” said a medical oncologist.

Because this disease seldom produces initial signs, it’s frequently diagnosed only after the disease is advanced. Even when a patient has symptoms they are often vague and may be confused with a several common illnesses.

“As of yet, there is no good way to identify this malignancy in the initial phases, apart from paying attention to physical changes and speaking with your physician if there are unfamiliar signs,” explained a medical director.

Common symptoms of pancreatic cancer encompass:

• abdominal or lower back pain
• reduced body mass
• jaundice
• reduced hunger
• dark urine
• pale or fatty bowel movements
• diarrhea
• excessive hunger or thirst
• nausea

At age 51, D’Angelo’s death is an outlier, as this malignancy is most common in individuals in the sixty-five to seventy-five age bracket. However, numerous malignancies, such as this type, have become increasingly prevalent in younger adults.

“This disease identified prior to fifty is deemed uncommon, yet alarmingly, clinicians are noticing a growing number of younger individuals affected by this condition,” commented a specialist.

Genetic Background Affects Disease Probability

Without effective detection methods for pancreatic cancer, experts stressed the significance of understanding your relatives’ cancer history. Some risk factors, such as smoking and excess weight also have an influence in the onset of this disease.

Black individuals have the highest incidence of this malignancy in the U.S. and are most likely to be diagnosed with inoperable cancer.

“The initial action toward lowering one’s risk of this condition is assessing individual susceptibility. People should examine their family history, hereditary factors, and medical conditions, such as blood sugar disease, chronic pancreatitis, or obesity that may raise their susceptibility,” said a specialist.

Inherited genetic risk factors are linked to as much as ten percent of all this malignancy cases. If a relative in your family has had pancreatic cancer, you may want to consider genetic testing.

“For people with a relative’s background of this condition or those having elevated risk genetic mutations, screening may involve sophisticated scans such as magnetic resonance imaging (MRI) or internal ultrasound to find early changes in the pancreas,” he explained.

For those looking to lower their chance, lifestyle changes may make a difference. The most effective action you can take to reduce your susceptibility of pancreatic cancer is to stop tobacco use, and if you don’t smoke, stay away altogether.

Heavy alcohol consumption is associated with pancreas inflammation, a contributing element for pancreatic cancer, so reducing or avoiding drinks may help lower your chance.

Controlling your weight or losing weight may also aid decrease your susceptibility. People with excess weight are twenty percent more prone to develop this disease. This malignancy also is more frequent in those with blood sugar issues, and reducing weight can also reduce the chance of type 2 diabetes.

Despite pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are doing better with treatments and more recent mixed drug treatments. There are emerging targeted therapies that are already showing results,” remarked a specialist.

For many people, however, awareness about this uncommon but {dev